Literature DB >> 24071379

Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum.

Juliana Tonini Mesquita1, Erika Gracielle Pinto, Noemi Nosomi Taniwaki, Andres Jimenez Galisteo, Andre Gustavo Tempone.   

Abstract

Studying the cellular death pathways in Leishmania is an important aspect of discovering new antileishmanials. While using a drug repositioning approach, the lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide (NTZ) was investigated against Leishmania (L.) infantum. The in vitro antileishmanial activity and cytotoxicity were assessed using both parasite stages and mammalian NCTC cells, respectively. The lethal action of NTZ was investigated by detecting the phosphatidylserine (PS) exposure, reactive oxygen species (ROS) regulation, plasma membrane permeability, mitochondrial membrane potential and ultrastructural modifications by transmission electron microscopy. NTZ's activity against L. infantum was confirmed, producing IC50 values of 42.71μg/mL against promastigotes and 6.78μg/mL against intracellular amastigotes. NTZ rapidly altered the cellular metabolism of promastigotes by depolarising the mitochondrial membrane and up-regulating the reactive oxygen species (ROS). In addition, the flow cytometry data revealed an intense and time-dependent exposure of PS in promastigotes. When using SYTOX(®) Green as a fluorescent probe, NTZ demonstrated no interference in plasma membrane permeability. The ultrastructural alterations in promastigotes were time-dependent and caused chromatin condensation, plasma membrane blebbing and mitochondrial swelling. These data suggest that NTZ induced oxidative stress in L. (L.) infantum and might be a useful compound for investigating new therapeutic targets.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Leishmania; Mitochondria; Nitazoxanide; Oxidative stress; Phosphatidylserine; Therapy

Mesh:

Substances:

Year:  2013        PMID: 24071379     DOI: 10.1016/j.actatropica.2013.09.018

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  10 in total

Review 1.  Liposomal drug delivery systems for the treatment of leishmaniasis.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Regina Maia de Souza; Victoria Stadler Tasca Ribeiro; Valdir Sabbaga Amato
Journal:  Parasitol Res       Date:  2022-09-16       Impact factor: 2.383

2.  Heterologous Expression and Characterization of a Full-length Protozoan Nitroreductase from Leishmania orientalis isolate PCM2.

Authors:  Panu Pimviriyakul; Yuvarun Kapaothong; Theerapat Tangsupatawat
Journal:  Mol Biotechnol       Date:  2022-08-30       Impact factor: 2.860

3.  Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.

Authors:  Paula S Lage; Miguel A Chávez-Fumagalli; Juliana T Mesquita; Laís M Mata; Simone O A Fernandes; Valbert N Cardoso; Manuel Soto; Carlos A P Tavares; João P V Leite; Andre G Tempone; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

4.  Anti-apoptotic effects of Sonic hedgehog signalling through oxidative stress reduction in astrocytes co-cultured with excretory-secretory products of larval Angiostrongylus cantonensis.

Authors:  Kuang-Yao Chen; Cheng-Hsun Chiu; Lian-Chen Wang
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

Review 5.  Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.

Authors:  Rebecca L Charlton; Bartira Rossi-Bergmann; Paul W Denny; Patrick G Steel
Journal:  Parasitology       Date:  2017-08-14       Impact factor: 3.234

6.  PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum.

Authors:  Patrícia de Almeida Machado; Pollyanna Stephanie Gomes; Victor Midlej; Elaine Soares Coimbra; Herbert Leonel de Matos Guedes
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

7.  Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis.

Authors:  Husna Khalid; Sibgha Batool; Fakhar Ud Din; Salman Khan; Gul Majid Khan
Journal:  R Soc Open Sci       Date:  2022-10-05       Impact factor: 3.653

8.  Investigation of Calcium Channel Blockers as Antiprotozoal Agents and Their Interference in the Metabolism of Leishmania (L.) infantum.

Authors:  Juliana Quero Reimão; Juliana Tonini Mesquita; Daiane Dias Ferreira; Andre Gustavo Tempone
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

9.  Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study.

Authors:  Erika Gracielle Pinto; Leandro R S Barbosa; Renato A Mortara; Andre Gustavo Tempone
Journal:  Chem Biol Interact       Date:  2020-10-20       Impact factor: 5.192

10.  In vitro anti-Leishmania activity of 8-hydroxyquinoline and its synergistic effect with amphotericin B deoxycholate against Leishmania martiniquensis.

Authors:  Wetpisit Chanmol; Padet Siriyasatien; Nuchpicha Intakhan
Journal:  PeerJ       Date:  2022-01-18       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.